Skip to content
  • Sunday, 26 July 2026
  • 3:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Existing Chronic Constipation Medication Demonstrates Significant Potential to Alleviate Lingering Cognitive Deficits in Post-Depression Recovery
Neuroscience & Brain Research

Existing Chronic Constipation Medication Demonstrates Significant Potential to Alleviate Lingering Cognitive Deficits in Post-Depression Recovery

Rifan Muazin Jul 16, 2026 0

While the clinical treatment of major depressive disorder has historically focused on stabilizing mood and emotional regulation, a significant portion…

Read More
Advanced Materials Science

The Environmental Legacy of Pyrotechnics: New Scientific Insights into Post-Celebratory Pollution

Nila Kartika Wati Jul 6, 2026 0

The vivid streaks of crimson, emerald, and gold that illuminate the night sky during national holidays and global festivities have…

Read More
Data Science & Bioinformatics

The Imperative of Calibrating Large Language Models: A Deep Dive into Post-Hoc Methods for Enhanced Trustworthiness.

Evan Lee Salim Jun 6, 2026 0

The reliability of artificial intelligence, particularly large language models (LLMs), hinges significantly on their ability to accurately express confidence in…

Read More
Laboratory Automation & Robotics

BioNTech’s Post-Pandemic Pivot: From €19 Billion Vaccine Bonanza to Oncology’s €16.8 Billion Bet Amidst Job Cuts and Shifting mRNA Landscape

Lana Keisha May 28, 2026 0

The German biotechnology firm BioNTech, a name synonymous with the rapid development of the world’s first widely authorized mRNA COVID-19…

Read More
Pharmaceutical R&D

Paradigm Health Launches SPIRE Platform to Revolutionize Post-Approval Oncology Research

Teuku Ryan May 23, 2026 0

The landscape of oncology therapeutics is rapidly evolving, with groundbreaking treatments continuously emerging and receiving regulatory approval. However, the journey…

Read More
Neuroscience & Brain Research

The Neural Blueprint of Fitness: How Post-Exercise Brain Activity Drives Long-Term Physical Endurance and Metabolic Adaptation

Rifan Muazin May 17, 2026 0

The traditional understanding of physical fitness has long been centered on the periphery of the human body, focusing on the…

Read More
Pharmaceutical R&D

Foundayo Demonstrates Efficacy in Sustaining Weight Loss Post-Injectable Incretin Therapy, Presenting a Novel Oral Option

Teuku Ryan May 14, 2026 0

On May 13, 2024, at the 33rd European Congress on Obesity (ECO) held in Istanbul, Türkiye, groundbreaking Phase 3b trial…

Read More
Clinical Diagnostics & Pathology

Donor-Derived Cell-Free DNA Testing Revolutionizes Post-Transplant Surveillance, Offering Early Organ Injury Detection and Reducing Invasive Biopsies

Reynand Amr Wu Mar 19, 2026 0

A groundbreaking blood test measuring donor-derived cell-free DNA (dd-cfDNA) is fundamentally transforming post-transplant patient management, providing clinical laboratories with an…

Read More
The Physics of Follicles: New Research Uncovers a Surprising Mechanism of Human Hair GrowthRethinking Metabolic Control: How Astrocytes and Tanycytes Drive Brain Signaling for Hunger and SatietyUnderstanding Osteopenia: The Global Silent Epidemic of Bone Density Loss and the Path to PreventionTWiV 1290: Clinical update with Dr. Daniel Griffin | Microbe TV
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ